PlainBillCongress, translated.Legislation. Context. Public interest.Referred to the Subcommittee on Health and Environment.
Congressional Research Service
Version 00 · Introduced in House · Sep 16, 1998
Dietary Supplement Fairness in Advertising Act - Amends the Federal Trade Commission Act to declare that an advertisement for a dietary ingredient or supplement is not unfair competition or a deceptive act or practice if it is made consistent with: (1) certain provisions of the Federal Food, Drug, and Cosmetic Act (FDCA) relating to dietary supplements; and (2) the amendments made by this Act. Requires that, before the Federal Trade Commission determines whether an advertisement or advertiser is in FDCA compliance, the advertiser have the opportunity to consult directly with any scientific expert that advised the Commission concerning the applicability of FDCA provisions to the dietary ingredient or supplement. Declares that the inclusion, in an advertisement for a dietary ingredient or supplement meeting FDCA requirements, of truthful information that is not misleading concerning the usefulness or potential usefulness of an ingredient or supplement based on a study related to that ingredient or supplement is not unfair competition or a deceptive act or practice if that information identifies the type of study (in vitro, human, animal, epidemiological, or other) in the advertisement. Requires that, when the Commission makes a consent agreement regarding a complaint of unfair competition or a deceptive act or practice concerning the advertisement of a dietary ingredient or dietary supplement, the agreement cover only the ingredient or supplement class that is the subject of the complaint.
People & committees
Rep. Crapo, Mike [R-ID-2] · R–ID
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to the Subcommittee on Health and Environment.
Referred to the Subcommittee on Telecommunications, Trade, and Consumer Protection.
Referred to the House Committee on Commerce.
Sponsor introductory remarks on measure. (CR E1732)
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Jun 3, 2026. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.4581 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.4581 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.4581 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.4581 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.